Skechers' Sketchy Claims Result in a $40 Million Fine
Washington, DC: It turns out that Skechers was an unfortunate name for a shoe company made to eat $40 million worth of crow at the behest of the Federal Trade Commission (FTC). That's because of allegations surrounding false and misleading claims related to their shoe line. While this was not a
Skechers Shape-Up lawsuit and Skechers was not required to admit to any wrongdoing, the $40 million fine implies just that
[READ MORE]
Yasmin Litigation Update
Washington, DC: Attorneys representing
Yasmin and Yaz plaintiffs nationwide are being contacted by Bayer to possibly reach settlements for their clients with pulmonary embolism and/or deep vein thrombosis (DVT) claims. One Yasmin attorney advises all claimants to ascertain whether their lawyer has been contacted by Bayer to reach a settlement and whether the amount offered by Bayer is fair
[READ MORE]
Fosamax: Safe and Risky at the Same Time
Washington, DC: Even when a study appears to clear a drug from possible suspicion of harm, as might be the case with
Fosamax side effects, the possibility is rarely, if ever, ruled out. Such is the case with the study "Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort," which was published earlier this month in the
Journal of Bone and Mineral Research [READ MORE]